Michael Vigilante
About Michael Vigilante
Michael Vigilante serves as the Vice President of Investments and Business Development at Ligand Pharmaceuticals. He has a background in finance and biology, having previously held positions at Gurnet Point Capital and MTS Health Partners.
Current Role at Ligand Pharmaceuticals
Michael Vigilante serves as the Vice President of Investments and Business Development at Ligand Pharmaceuticals. He has held this position since 2024 and is based in Boston, Massachusetts. In this role, he is responsible for overseeing investment strategies and business development initiatives within the company.
Previous Experience at Gurnet Point Capital
Prior to his current role, Michael Vigilante worked at Gurnet Point Capital as a Senior Principal from 2014 to 2024. During his ten years at the firm, located in Cambridge, Massachusetts, he contributed to various investment projects and strategic initiatives, enhancing the firm's portfolio and market presence.
Experience at MTS Health Partners
Michael Vigilante began his career as an Analyst at MTS Health Partners, where he worked from 2012 to 2014. In this role, he gained valuable experience in financial analysis and investment strategies within the healthcare sector, which laid the groundwork for his future positions.
Educational Background
Michael Vigilante studied at the University of Pennsylvania, where he earned a Bachelor of Arts in Biology from 2008 to 2012. Additionally, he attended The Wharton School, obtaining a Bachelor of Science in Economics with a focus on Finance during the same period. His education provided a strong foundation in both the biological sciences and financial principles.